Mohammed Omer Mohammed *, Bushra Mohammed Ali *and Suheila Shams-el-den Tahir **

*     Department of Medicine, School of Medicine, Faculty of Medical Sciences , University of Sulaimani.

**   Department of Family and community Medicine, School of Medicine, Faculty of Medical Sciences , University of Sulaimani.

*** Kirkuk Directorate of Health. 

Submitted: 28/4/2011; Accepted: 14/9/2011; Published 1/12/2011

DOI Link: https://doi.org/10.17656/jsmc.10015 



Tuberculosis has got high priority within the health sector as a major public health problem and directly observed therapy short course (DOTS) strategy has been planned to be implemented widely to control the disease and its management.


To assess knowledge of the patients’ on various aspects of tuberculosis and show the six mutually exclusive outcome of treatment regimen under directly observed therapy short course (DOTS).

Patients and Methods 

A prospective case follow up study has been carried out on 110 patients attending consultation clinic for Chest and Respiratory Diseases in Kirkuk, for the period from the 1st of April to 31st of December 2009.Tuberculous patients were followed up for the next six months period under DOTS program including two phases


Regarding knowledge of patients about routes of transmission and risk factors, there was statistically significant difference between different educational levels (P<0.05), the highest percentage being among secondary school level patients (28.6%). Occupation had a significant effect on patients’ knowledge on treatment regimen , in high score knowledge group (4-6) among students was 100%which was statistically significant. The outcome of treatment regimen was 99.1% treatment success (cure and completed treatment); 0.9% had relapsed and no unfavorable outcome was noticed.


Overall knowledge of patients was low regarding routes of transmission, risk factors and treatment regimen.


Tuberculosis, DOTS, WHO, Kirkuk.


1. Wartan SW. Dots implementation in Iraq: 5 year evaluation and expected outcome in 2010. Med J Basrah Univ 2005; 23: 54-61.

2. World Health Organization. Global DOTS Expansion Plan Progress in TB control in high burden countries. WHO 2001; 4-16.

3. Leena S, Prasad SN. A cohort analysis of performance of RNTCP in Karnatako. NTI Bulletin 2006; 42(3&4): 95-101.

4-Hashim DS, Al-Kubaisy W, Al-Dulayme A. Knowledge, attitudes and practices survey among health care workers and tuberculosis patients in Iraq. East Mediterr Health J 2003; 9(4): 718-731.

5-World Health Organization. Beyond DOTS- The new stop TB strategy and its implementation. 11th meeting Secretaries of Member States of SEAR SEARO, New Delhi, India, 12-13 June, 2006.

6-Jackson AD, McMenamin J, Brewster N, Ahmed S, Reid ME. Knowledge of tuberculosis transmission among recently infected patients in Glasgow. Public Health 2008; 122(10): 1004-1012.

7-World Health Organization. Retreatment of tuberculosis: guidelines for national programmes. WHO, Geneva. Report No WHO/CDC/TB/ 2003; 313.

8-Daniel WW. Biostatistics a foundation for analysis in the health sciences, 8th edit. Wiley & Sons, Inc. Georgia state, U.S.A. 2005; PP 284 .

9-Hill PC, Jackson-Sillah D, Donkor SA, Otu J, Adegbola RA, Lienhardt C.  Risk factors for pulmonary tuberculosis: a clinical-based case control study in Gambia. BMC Public Health 2006; 6: 156.

10-Mohammed AL, Yousif MA, Ottoa P, Bayoumi A. Knowledge of tuberculosis: a survey among tuberculosis patients in Omdurman, Sudan. Sudanese J Public Hlth 2007; 2(1): 1-8.

11-Gopi PG, Vasanthaa M, Muniyandi M, Chandrsasekaran V, Balasubramanian R, Narayanan PR. Risk factors for non-adherence to directly observed treatment. Ind J Tuberc 2007; 54: 66-70.

12-Hashem DS, Wartan SW. Guide line of National Tuberculosis Control in Iraq. Ministry of Health, Baghdad, Iraq.3rd edition. Ministry of Health, Iraq. 2007.

13-Centers for Disease Control and Prevention. Essential components of a tuberculosis prevention and control program. Morbid Mortal. Weekly Rep 1995; 44(11): 1-34.

14-Cummings KC, Mohle-Boetani J, Royce SE, Chin DP. Movement of tuberculosis patients and the failure to complete anti tuberculosis treatment. Am J Respir Crit Care Med 1998; 157(4): 1249-1252.

15-Mohan A, Nassir H, Niazi A. Does routine home visiting improve the return rate and outcome of DOTS patients who delay treatment? East Mediterr Health J.  2003; 9(4): 702-708.

16-Abbasi A, Mansourian AR. Efficacy of DOTS strategy in treatment of respiratory tuberculosis in Gorgan, Islamic Republic of Iran. East Mediterr Health J. 2007; 13(3): 1-6.

17-Niazi AD, Al-Delaimi AM. Impact of community participation on treatment outcomes of DOTS patients in Iraq. East Mediterr Health J. 2003; 9(4): 1-9.

18- Al-Hajjaj M. The outcome of tuberculosis treatment after implementation of the national tuberculosis control program in Saudi Arabia. Ann Saudi Med 2000; 20(2): 125-128.

19-World Health Organization. Report on subregional meeting on TB control in the countries of Near East, Damascus-Syrian Arab Republic, 30 May-I June 1998.

20-Chadha SL, Bhagi RP. Treatment outcome in tuberculosis patients placed under directly treatment short course (DOTS)-A Cohort study. Ind J Tuber 2000; 47: 155-159.

21-Qing-Song Bao, Yu-Hua DU, Ci-Yong Lu. (2007) Treatment outcome of new pulmonary tuberculosis in China 1993-2002: a register-based cohort study. BMC Public Health 2007; 7: 344-355.

22-Vieira AA, Ribeiro SA, Noncompliance with tuberculosis treatment involving self.

23-Demissie M, Getahun H, Lindtjorn B. Community tuberculosis care through TB clubs in rural North Ethiopia. Soc Sci and Med 2003; 56: 2009-2018.

24-Anuwatnonthakate A, Limsomboon P, Wattanaamornkiat W. Directly observed therapy and improved tuberculosis outcome in Thailand. PloS. 2008; 3(8): e3089.

25- Hoa NP, Diwan VK, Co NV, Thorson AE. Knowledge about tuberculosis and its treatment among new pulmonary TB patients in the north and central regions of Vietnam. Int J Tuberc Lung Dis 2004; 8(5): 603-608.

Full Text

 © The Authors, published by University of Sulaimani, College of Medicine

This work is licensed under a Creative Commons Attribution 4.0 International License.